Connor Clark & Lunn Investment Management Ltd. Buys 370,672 Shares of Sarepta Therapeutics, Inc. $SRPT
Connor Clark & Lunn Investment Management Ltd. boosted its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 151.4% in the 2nd quarter, according to its most recent disclosure with...